BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 23608763)

  • 1. Chalcones, inhibitors for topoisomerase I and cathepsin B and L, as potential anti-cancer agents.
    Kim SH; Lee E; Baek KH; Kwon HB; Woo H; Lee ES; Kwon Y; Na Y
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3320-4. PubMed ID: 23608763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and topoisomerase II inhibitory and cytotoxic activity of oxiranylmethoxy- and thiiranylmethoxy-chalcone derivatives.
    Na Y; Nam JM
    Bioorg Med Chem Lett; 2011 Jan; 21(1):211-4. PubMed ID: 21115246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, cytotoxicity and topoisomerase inhibition properties of multifarious aminoalkylated indeno[1,2-c]isoquinolin-5,11-diones.
    Ahn G; Schifano-Faux N; Goossens JF; Baldeyrou B; Couture A; Grandclaudon P; Lansiaux A; Ryckebusch A
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2259-63. PubMed ID: 21439821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4β-[4'-(1-(Aryl)ureido)benzamide]podophyllotoxins as DNA topoisomerase I and IIα inhibitors and apoptosis inducing agents.
    Kamal A; Suresh P; Ramaiah MJ; Srinivasa Reddy T; Kapavarapu RK; Rao BN; Imthiajali S; Lakshminarayan Reddy T; Pushpavalli SN; Shankaraiah N; Pal-Bhadra M
    Bioorg Med Chem; 2013 Sep; 21(17):5198-208. PubMed ID: 23849207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids: synthesis, physicochemical properties, anticancer and topoisomerase I and II inhibitory activity.
    Abdel-Aziz M; Park SE; Abuo-Rahma Gel-D; Sayed MA; Kwon Y
    Eur J Med Chem; 2013 Nov; 69():427-38. PubMed ID: 24090914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of novel ellipticines as potential anti-cancer agents.
    Deane FM; O'Sullivan EC; Maguire AR; Gilbert J; Sakoff JA; McCluskey A; McCarthy FO
    Org Biomol Chem; 2013 Feb; 11(8):1334-44. PubMed ID: 23314103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suzuki coupling based synthesis and in vitro cytotoxic evaluation of 7-heteroaryl-substituted camptothecin analogs.
    Wang L; Huang Y; Zhang J; Tong L; Chen Y; Lu W; Huang Q
    Bioorg Med Chem Lett; 2014 Mar; 24(6):1597-9. PubMed ID: 24529870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of 2-phenyl- or hydroxylated 2-phenyl-4-aryl-5H-indeno[1,2-b]pyridines.
    Kadayat TM; Song C; Shin S; Magar TB; Bist G; Shrestha A; Thapa P; Na Y; Kwon Y; Lee ES
    Bioorg Med Chem; 2015 Jul; 23(13):3499-512. PubMed ID: 26022080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutral and ionic platinum compounds containing a cyclometallated chiral primary amine: synthesis, antitumor activity, DNA interaction and topoisomerase I-cathepsin B inhibition.
    Albert J; Bosque R; Crespo M; Granell J; López C; Martín R; González A; Jayaraman A; Quirante J; Calvis C; Badía J; Baldomà L; Font-Bardia M; Cascante M; Messeguer R
    Dalton Trans; 2015 Aug; 44(30):13602-14. PubMed ID: 26140359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SAR studies of differently functionalized chalcones based hydrazones and their cyclized derivatives as inhibitors of mammalian cathepsin B and cathepsin H.
    Raghav N; Singh M
    Bioorg Med Chem; 2014 Aug; 22(15):4233-45. PubMed ID: 24913985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic chalcone derivatives as inhibitors of cathepsins K and B, and their cytotoxic evaluation.
    Ramalho SD; Bernades A; Demetrius G; Noda-Perez C; Vieira PC; Dos Santos CY; da Silva JA; de Moraes MO; Mousinho KC
    Chem Biodivers; 2013 Nov; 10(11):1999-2006. PubMed ID: 24243608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors.
    My Van HT; Woo H; Jeong HM; Khadka DB; Yang SH; Zhao C; Jin Y; Lee ES; Youl Lee K; Kwon Y; Cho WJ
    Eur J Med Chem; 2014 Jul; 82():181-94. PubMed ID: 24904965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of novel benzoxanthone analogues as non-Camptothecin topoisomerase I inhibitors.
    Cheng P; Zhu L; Guo W; Liu W; Yao J; Dong G; Zhang Y; Zhuang C; Sheng C; Miao Z; Zhang W
    J Enzyme Inhib Med Chem; 2012 Jun; 27(3):437-42. PubMed ID: 21770860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L.
    Parker EN; Song J; Kishore Kumar GD; Odutola SO; Chavarria GE; Charlton-Sevcik AK; Strecker TE; Barnes AL; Sudhan DR; Wittenborn TR; Siemann DW; Horsman MR; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem; 2015 Nov; 23(21):6974-92. PubMed ID: 26462052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, topoisomerase I & II inhibitory activity, antiproliferative activity, and structure-activity relationship study of pyrazoline derivatives: An ATP-competitive human topoisomerase IIα catalytic inhibitor.
    Ahmad P; Woo H; Jun KY; Kadi AA; Abdel-Aziz HA; Kwon Y; Rahman AF
    Bioorg Med Chem; 2016 Apr; 24(8):1898-908. PubMed ID: 26988802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and topoisomerases inhibitory activity of heteroaromatic chalcones.
    Jeon KH; Yu HB; Kwak SY; Kwon Y; Na Y
    Bioorg Med Chem; 2016 Nov; 24(22):5921-5928. PubMed ID: 27707625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational screening of chalcones acting against topoisomerase IIα and their cytotoxicity towards cancer cell lines.
    Sangpheak K; Mueller M; Darai N; Wolschann P; Suwattanasophon C; Ruga R; Chavasiri W; Seetaha S; Choowongkomon K; Kungwan N; Rungnim C; Rungrotmongkol T
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):134-143. PubMed ID: 30394113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and investigation of dihydroxychalcones as calpain and cathepsin inhibitors.
    Baek KH; Karki R; Lee ES; Na Y; Kwon Y
    Bioorg Chem; 2013 Dec; 51():24-30. PubMed ID: 24095934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Arylisoquinolines as novel topoisomerase I inhibitors.
    Khadka DB; Cho WJ
    Bioorg Med Chem; 2011 Jan; 19(2):724-34. PubMed ID: 21095131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and antiproliferative evaluation of fluorenone analogs with DNA topoisomerase I inhibitory properties.
    Lee CC; Chang DM; Huang KF; Chen CL; Chen TC; Lo Y; Guh JH; Huang HS
    Bioorg Med Chem; 2013 Nov; 21(22):7125-33. PubMed ID: 24094433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.